
Opioid Epidemic Decline in North America: Glimmer of Hope Amidst Ongoing Challenges
カートのアイテムが多すぎます
ご購入は五十タイトルがカートに入っている場合のみです。
カートに追加できませんでした。
しばらく経ってから再度お試しください。
ウィッシュリストに追加できませんでした。
しばらく経ってから再度お試しください。
ほしい物リストの削除に失敗しました。
しばらく経ってから再度お試しください。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
このコンテンツについて
Canada, despite population differences, continues to struggle with high rates. From January 2016 to December 2024, Canada recorded over 52,500 apparent opioid toxicity deaths. In 2024, three provinces—British Columbia, Alberta, and Ontario—were home to 80% of these losses. Fentanyl, a powerful synthetic opioid that was originally intended for medical use but now dominates illicit markets, was involved in about 74% of opioid toxicity deaths in 2024. Equally troubling is that stimulants like methamphetamine co-occurred in 70% of opioid deaths, illustrating the poly-drug reality fueling today’s crisis, according to Health Canada. Most Canadian deaths—84%—involved non-pharmaceutical opioids, revealing the dangerous shift away from prescription sources to illicit markets.
Throughout the past decade, North America’s opioid crisis has been shaped by cycles of prescription opioid abuse, a surge in heroin use, and, most dangerously, waves of synthetic opioids like fentanyl. Declines in prescription opioid and heroin-related deaths have been observed—in the U.S. a 12% drop for prescription opioids and 33% for heroin from 2022 to 2023, per the CDC—but the supply of illicit fentanyl continues to be catastrophic. Fentanyl is up to 100 times stronger than morphine, and it often appears as an unmarked, deadly additive in street drugs, causing many users to be unaware of the risk, as the World Health Organization emphasizes.
While the decline in recent overdose deaths provides some breathing room, underlying
Some great Deals https://amzn.to/49SJ3Qs
For more check out http://www.quietplease.ai
まだレビューはありません